Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano, Via Balzaretti 9, 20133, Milan, Italy.
Neuropsychopharmacology Lab, Section Pharmacology, Dept Diagnostic & Public Health, P.le Scuro 10, University of Verona, Verona, Italy.
Neuropharmacology. 2024 Jan 1;242:109767. doi: 10.1016/j.neuropharm.2023.109767. Epub 2023 Oct 17.
Despite several decades of investigations, the mechanisms underlying the rapid action of ketamine as antidepressant are still far from being completely understood. Several studies indicated Brain-Derived Neurotrophic Factor (BDNF) as critical for the fast antidepressant action of ketamine, due to its contribution in early and rapid synaptic adaptations. However, previous reports have been essentially based on ketamine dosing modes that differ from the clinical route of administration (slow intravenous infusion). In this report, we investigated the effects of a ketamine dosing mode in male Sprague-Dawley rats showed to be translational to the clinically effective mode in patients. We focused on the first 24 h after infusion to finely dissect potential differences in the contribution of BDNF signaling pathway in prefrontal cortex and hippocampus, two brain regions involved in the antidepressant effects of ketamine. Our data show that the slow ketamine infusion activates the BDNF-mTOR-S6 pathway in prefrontal cortex as early as 2 h and remains on until at least 6 h after the infusion. At the 12 h timepoint, this pathway is turned off in prefrontal cortex while it becomes activated in hippocampus. Interestingly, this pathway appears to be activated in both brain regions at 24 h through a BDNF-independent mechanism adding complexity to the early action of ketamine. We have captured previously unknown dynamics of the early effects of ketamine showing rapid activation/deactivation of BDNF and its downstream signaling in prefrontal cortex and hippocampus, following a precise temporal profile.
尽管经过了几十年的研究,氯胺酮作为抗抑郁药的快速作用机制仍远未完全被理解。几项研究表明,脑源性神经营养因子(BDNF)对于氯胺酮的快速抗抑郁作用至关重要,因为它有助于早期和快速的突触适应。然而,以前的报告基本上基于与临床给药途径(缓慢静脉输注)不同的氯胺酮给药模式。在本报告中,我们研究了一种在雄性 Sprague-Dawley 大鼠中显示与患者中临床有效模式具有转化性的氯胺酮给药模式的影响。我们重点研究了输注后 24 小时内的情况,以精细剖析 BDNF 信号通路在额皮质和海马体中的潜在差异,这两个脑区都参与了氯胺酮的抗抑郁作用。我们的数据表明,缓慢的氯胺酮输注早在 2 小时就激活了额皮质中的 BDNF-mTOR-S6 通路,并持续到输注后至少 6 小时。在 12 小时时间点,该通路在额皮质中被关闭,而在海马体中被激活。有趣的是,该通路似乎通过一种 BDNF 独立的机制在两个脑区中在 24 小时被激活,这为氯胺酮的早期作用增加了复杂性。我们已经捕捉到了氯胺酮早期作用的以前未知的动力学,显示了 BDNF 及其下游信号在额皮质和海马体中的快速激活/失活,遵循精确的时间模式。